AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Activity
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

61 hedge funds and large institutions have $42.3M invested in AVEO Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-7
Holders Change %
-10.29%
% of All Funds
1.75%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
10
Increased
12
Reduced
26
Closed
16
Calls
$7K
Puts
$81K
Net Calls
-$74K
Net Calls Change
-$52K

Top Buyers

1
FRM
1
Fore Research & Management
New York
$1.23M
2
GCM
2
Gruss Capital Management
New York
$976K
3
Bank of America
3
Bank of America
North Carolina
$428K
4
PP
4
Paloma Partners
Connecticut
$409K
5
COPPSERS
5
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$270K

Top Sellers

1
BFA
1
BlackRock Fund Advisors
California
$288K
2
State Street
2
State Street
Massachusetts
$53K
3
GPP
3
Great Point Partners
Connecticut
$4.26M
4
SM
4
Sabby Management
Florida
$0
5
BIT
5
BlackRock Institutional Trust
California
$3.96M
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
76
Prelude Capital Management
New York
– -$2K -120 Closed
1 2 3
4